EU Medicines AgencyVerified account

@EMA_News

Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.

Amsterdam, The Netherlands
ema.europa.eu
Joined February 2010
913 Photos and videos Photos and videos

Tweets

You blocked @EMA_News

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @EMA_News

  1. Retweeted
    15 hours ago

    The last EMA-EUnetHTA Bilateral Meeting under Joint Action 3 was held today, concluding collaboration that began with the first bilateral meetings in 2010. EMA/EUnetHTA workplan 2017-2021 joint achievements were reviewed, then a "Cheers!" to the future was made.

    1 reply 4 retweets 13 likes
    Undo
  2. 15 hours ago

    For over 200 years, vaccines have saved millions of lives from deadly infectious diseases. Vaccines also allow people to come together without the fear of getting ill, this improves the quality of life and their wellbeing. Find out how :

    Vaccines are one of our greatest scientific innovations Offering protection from & reducing the spread of more than 2⃣0⃣serious & life-threatening diseases like measles, pneumonia & cervical cancer Find out more:
    1 reply 22 retweets 44 likes
    Undo
  3. 15 hours ago

    As we dive deeply into , we must remember that . Vaccination is our way towards ending the pandemic and saving lives 🌎 Visit EMA’s website to get reliable information on :

    1:52
    Get your facts right! During the pandemic make sure you get your information from trusted sources! Watch our animation, visit our portal & don’t let anyone fool you! ! !
    Show this thread
    19 retweets 32 likes
    Undo
  4. Retweeted
    Apr 23

    Today, our lives are defined by COVID-19 What does this mean for our mental health & for those providing care? Join us on 10 May to discuss Mental health & the pandemic: living, caring, acting! Details & registration:

    4 replies 22 retweets 28 likes
    Undo
  5. Apr 26

    EMA and today kicked off a new initiative aimed at strengthening post-marketing monitoring of the safety, effectiveness and impact of vaccines in the EU/EEA. Read more: 👉

    10 replies 65 retweets 108 likes
    Undo
  6. Apr 26

    Thank you to all professionals involved in EMA activities in 2020. See highlights of involvement 👉 Read more on how healthcare professionals are involved in of 👉

    3 replies 15 retweets 29 likes
    Undo
  7. Apr 26

    Thank you to all involved in EMA activities during 2020. See highlights of involvement 👉 Did you know that patients participate in of Read more here 👉

    4 replies 17 retweets 51 likes
    Undo
  8. Retweeted
    Apr 25

    European Immunization Week is here. As vaccinations against are taking place, vaccine production has also been ramping up. In the EU, we have 53 manufacturing sites & we expect an annual production capacity of over 3 billion doses by year-end. More in ↓

    52 replies 289 retweets 618 likes
    Undo
  9. Retweeted
    Apr 25

    focused our attention on vaccination But for more than 200 years vaccines have protected billions of people from diseases all over the world and can bring us closer again:

    67 replies 151 retweets 445 likes
    Undo
  10. Apr 23

    Did you miss the press briefing on further assessment of data on Vaxzevria, the from AstraZeneca? You can watch it on EMA's YouTube channel:

    9 replies 24 retweets 51 likes
    Undo
  11. Apr 23

    EMA’s human medicines committee () recommends 8 for approval at its April 2021. 👉

    3 replies 6 retweets 19 likes
    Undo
  12. Apr 23

    Peter Arlett, Head of Data Analytics and Methods: “Our work goes on. The safety of all the is our top priority and all new data will be evaluated immediately and the public will be kept up to date.”

    5 replies 24 retweets 73 likes
    Undo
  13. Apr 23

    Peter Arlett, Head of Data Analytics and Methods: “The benefits of AstraZeneca vaccine outweigh the risks. The work introduced today puts the very rare blood clots into the context of hospitalisations prevented, intensive-care admissions prevented and deaths prevented.”

    12 replies 59 retweets 105 likes
    Undo
  14. Apr 23

    Noël Wathion, EMA’s Deputy Executive Director: "CHMP has recommended to continue giving a second dose of Vaxzevria 4 to 12 weeks after giving the first one in line with the product information."

    6 replies 114 retweets 176 likes
    Undo
  15. Apr 23

    Noël Wathion, EMA’s Deputy Executive Director: “EMA will continue to assess further information as it becomes available from ECDC, from the Member States, from the company to decide if its current conclusions should be changed in the light of further scientific evidence.”

    2 replies 11 retweets 31 likes
    Undo
  16. Apr 23

    Noël Wathion, EMA’s Deputy Executive Director: “Overall, the data show that the benefits of vaccination increase with age and with increasing levels of infection in the community.”

    1 reply 27 retweets 51 likes
    Undo
  17. Apr 23

    We are starting the press briefing on further assessment of data on Vaxzevria, the from AstraZeneca:

    2 replies 32 retweets 37 likes
    Undo
  18. Apr 23

    Analysis of data on Vaxzevria (formerly AstraZeneca) puts risks of very rare blood clots in the context of benefits for different age groups and different rates of infection inform national decisions on vaccine roll-out 👉

    7 replies 129 retweets 159 likes
    Undo
  19. Apr 23

    !! A press briefing following the further assessment of Vaxzevria by our human medicines committee () is planned at 16:00 CET today 👉

    4 replies 25 retweets 54 likes
    Undo
  20. Apr 23

    EMA has approved manufacturing changes that will increase capacity and supply of Pfizer/BioNTech & Moderna in the EU 👉

    14 replies 214 retweets 601 likes
    Undo

@EMA_News hasn't Tweeted yet.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·